Your browser doesn't support javascript.
loading
DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
Freyse, Ernst-Joachim; Berg, Sabine; Kohnert, Klaus-Dieter; Heinke, Peter; Salzsieder, Eckhard.
Affiliation
  • Freyse EJ; Institute of Diabetes 'Gerhardt Katsch' Karlsburg, D-17495 Karlsburg, Germany. freyse@diabetes-karlsburg.de
Biol Chem ; 392(3): 209-15, 2011 Mar.
Article in En | MEDLINE | ID: mdl-21281062
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Gastric Inhibitory Polypeptide / Glucagon-Like Peptide 1 / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Insulin Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biol Chem Journal subject: BIOQUIMICA Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Gastric Inhibitory Polypeptide / Glucagon-Like Peptide 1 / Dipeptidyl-Peptidase IV Inhibitors / Incretins / Insulin Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biol Chem Journal subject: BIOQUIMICA Year: 2011 Document type: Article Affiliation country: Country of publication: